1. Home
  2. SEB vs ACAD Comparison

SEB vs ACAD Comparison

Compare SEB & ACAD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

SEB

Seaboard Corporation

HOLD

Current Price

$4,187.27

Market Cap

4.3B

Sector

Industrials

ML Signal

HOLD

ACAD

ACADIA Pharmaceuticals Inc.

HOLD

Current Price

$28.63

Market Cap

4.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SEB
ACAD
Founded
1918
1993
Country
United States
United States
Employees
N/A
N/A
Industry
Farming/Seeds/Milling
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.3B
4.3B
IPO Year
1994
2000

Fundamental Metrics

Financial Performance
Metric
SEB
ACAD
Price
$4,187.27
$28.63
Analyst Decision
Buy
Analyst Count
0
22
Target Price
N/A
$30.55
AVG Volume (30 Days)
3.3K
1.6M
Earning Date
05-12-2026
05-06-2026
Dividend Yield
0.17%
N/A
EPS Growth
467.71
69.12
EPS
283.99
0.20
Revenue
$5,809,000,000.00
$726,437,000.00
Revenue This Year
N/A
$18.80
Revenue Next Year
N/A
$11.70
P/E Ratio
$15.07
$142.25
Revenue Growth
7.99
40.45
52 Week Low
$3,140.01
$19.69
52 Week High
$5,989.37
$29.48

Technical Indicators

Market Signals
Indicator
SEB
ACAD
Relative Strength Index (RSI) N/A N/A
Support Level N/A N/A
Resistance Level N/A N/A
Average True Range (ATR) 0.00 0.00
MACD 0.00 0.00
Stochastic Oscillator 0.00 0.00

Price Performance

Historical Comparison
SEB
ACAD

About SEB Seaboard Corporation

Seaboard Corp is a diversified group of companies that operate in agricultural, energy, and ocean transport businesses. The company is engaged in hog production, biofuel production, and pork processing in the United States; commodity trading and grain processing in Africa and South America; cargo shipping services in the U.S., Caribbean and Central and South America; sugar and alcohol production in Argentina; and electric power generation in the Dominican Republic. It also has an equity method investment in Butterball, LLC, a producer and processor of turkey products. The group's operating segments are; pork, commodity trading and milling, marine, liquid fuels, power, turkey, and others. It operates in 45 countries, with a concentration in the Caribbean, Central and South American region.

About ACAD ACADIA Pharmaceuticals Inc.

Acadia Pharmaceuticals Inc is a biopharmaceutical company focused on turning scientific promise to makes a difference for underserved neurological and rare disease communities around the world. It has two core franchises in neurological and rare diseases. Its neurological disease is anchored by the commercial product NUPLAZID (pimavanserin), which is the first and only drug approved by the U.S. (FDA) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis (PDP). Its rare disease is anchored by the commercial product DAYBUE, which is the first and only drug approved for the treatment of Rett syndrome. Its clinical-stage development efforts are focused on Alzheimer's disease psychosis, Lewy Body Dementia psychosis, and multiple other programs.

Share on Social Networks: